Why Oxford's Covid-19 vaccine trial was halted

Simple item page
dc.contributor.authorFielding, Burtram C.
dc.date.accessioned2024-10-03T08:55:46Z
dc.date.available2024-10-03T08:55:46Z
dc.date.issued2020
dc.descriptionClinical trials of one of most promising candidate vaccines has been suspended after a patient developed unexplained illness. AstraZeneca says it has suspended trials of the coronavirus vaccine it is developing with the University of Oxford after one of the trial volunteers fell ill. South Africa has also suspended the trial. On line for comment is Director of Research Development, Department of Medical BioSciences at UWC, Professor Burtram Fielding.
dc.identifier.citationC. Fielding, Burtram (2020). Why Oxford's Covid-19 vaccine trial was halted. University of Western Cape. Media. https://doi.org/10.25379/uwc.13116863.v1
dc.identifier.urihttps://doi.org/10.25379/uwc.13116863.v1
dc.identifier.urihttps://hdl.handle.net/10566/16237
dc.publisherUniversity of the Western Cape
dc.subjectCOVID-19
dc.subjectCaronavirus
dc.subjectSouth Africa
dc.subjectVirology
dc.titleWhy Oxford's Covid-19 vaccine trial was halted
dc.typeDataset

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
fielding_why oxford's covid-19 vaccine _2020.pdf
Size:
20.91 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

UWC Data